인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
DBpia AI
AI 에이전트
AI 아이디어
AI 리더
AI 뷰어
Citeasy
크롬 서지관리 다운로드
개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
피인용 0
초록·키워드
In this study, sought to develop Manganese Ferrite (MnFe₂O₄) based Magnetic Nano-cluster (MNC) for specifically designed for the detection of triple-negative breast cancer (TNBC) through the use of magnetic resonance imaging (MRI). The MnFe2O4 based MNC were synthesized utilizing a thermal decomposition method, which allowed for precise control over their structural properties. Following synthesis, the average size of the MNC was measured to be 69 ± 27.4 ㎚, a dimension that is optimal for effective imaging and cellular interactions. To evaluate the biocompatibility of the synthesized MNC, we conducted a series of cytotoxicity tests. These tests revealed that cellular viability remained above 82 % across all treatment concentrations, indicating that the MNC exhibit minimal cytotoxic effects even after intravenous injection. This finding is particularly significant as it underscores the potential safety of using MNC for in vivo applications. Subsequently, the MNC were administered intravenously into the tail vein of nude mice, and MRI imaging was performed at various time intervals to monitor their distribution and behavior within the biological system. The results demonstrated a notable enhancement of contrast in the imaging of the xenograft mouse model, which utilized MNC for visualization. This enhancement is indicative of the MNC’s efficacy in highlighting tumor sites, thus facilitating improved diagnostic capabilities. The implications of these findings are substantial, as they not only contribute to the advancement of imaging technologies but also pave the way for future clinical applications of MNC in oncology. We anticipate that these results will serve as a valuable foundation for ongoing research and development, ultimately leading to the establishment of MNC as a reliable diagnostic tool for patients diagnosed with TNBC, a particularly aggressive and challenging subtype of breast cancer.
본문·목차
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
UCI(KEPA) : I410-151-25-02-092447445
